Table 3.
Repeat ED visit within 30 days | Repeat ED visit within 90 days | Repeat ED visit within 1 year | ||||
---|---|---|---|---|---|---|
Crude (95% CI) |
Adjusted
1
(95% CI) |
Crude (95% CI) |
Adjusted
1
(95% CI) |
Crude (95% CI) |
Adjusted
1
(95% CI) |
|
Overall | ||||||
No bup/nx | Ref | Ref | Ref | Ref | Ref | Ref |
Bup/nx given | 0.60 (0.35–1.02) | 0.56 (0.33–0.96) | 0.48 (0.29–0.79) | 0.43 (0.27–0.69) | 0.66 (0.42–1.05) | 0.60 (0.39–0.92) |
No naloxone kit given | ||||||
No bup/nx | Ref | Ref | Ref | Ref | Ref | Ref |
Bup/nx given | 0.95 (0.13–6.97) | 1.10 (0.15–8.13) | 0.37 (0.03–4.88) | 0.50 (0.04–5.68) | 0.39 (0.03–5.66) | 0.52 (0.04–6.54) |
Naloxone kit given | ||||||
No bup/nx | Ref | Ref | Ref | Ref | Ref | Ref |
Bup/nx given | 1.73 (0.52–5.78) | 1.50 (0.45–5.07) | 3.46 (0.75–15.97) | 2.67 (0.63–11.28) | 2.38 (0.76–7.44) | 1.85 (0.63–5.44) |
Estimates of count ratio and 95% CIs generated from Poisson models.
Bold face font indicates statistical significance where P < 0.05.
Adjusted for age and domicile status.
ED, emergency department; CI, confidence interval; bup/nx, buprenorphine/naloxone; ref, reference.